跳至主要内容
临床试验/JPRN-jRCT1080221287
JPRN-jRCT1080221287未知3 期

Double-blind randomized study to compare the efficacy and safety of tamsulosin prolonged release tablet 0.4 mg with Harnal capsule 0.2 mg in patients with lower urinary tract symptoms (LUTS) associated with benign prostate hyperplasia (BPH)

Astellas Pharma Inc.0 个研究点目标入组 400 人开始时间: 2010年10月29日最近更新:

试验速览

阶段
3 期
入组人数
400

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
>= 51age old 至 ot applicable(—)
性别
Male

入选标准

  • A total I-PSS of 8 to 30
  • A maximum flow rate in range of 5-15 ml/s; Voided volume of 150 ml or over
  • Residual volume of 100ml or less
  • Prostate volume of 20ml or over

排除标准

  • 未提供

研究者

相似试验

进行中(未招募)
不适用
Randomized Double-blind Study Comparing the Efficacy of Duloxetine with Placebo in Patients with Chronic Low Back Pai
EUCTR2009-012713-22-ATMedizinische Universität Wien, Univ. Klinik für Anästhesie, Allg. Intensivmedizin u Schmerztherapie
已完成
3 期
Comparison of effect of methyl phenidate (Ritalin) and bupropion in children with hyperactivity disorderattention deficit hyperactivity disorder.Disturbance of activity and attention
IRCT201012295500N1Research vice chancellor of Mashad university of medical sciences40
尚未招募
4 期
To see which mode of administration of Injection nalbuphine is more effective in preventing itching caused by painkiller morphine
CTRI/2017/04/008332Shri Sathya Sai Medical College and Research Institute90
已完成
不适用
Double-blind randomised controlled study to compare the outcomes of laparoscopic gastric banding and laparoscopic Roux-en-Y gastric bypass in morbidly obese patients attending the Multidisciplinary Morbid Obesity Clinic at King's College Hospitalutritional, Metabolic, Endocrine: ObesityNutritional, Metabolic, EndocrineObesity
ISRCTN33929407Department of Health
进行中(未招募)
1 期
Efficacy and safety of trazodone OAD and venlafaxine XR in the treatment of Major Depressive Disorder.Major depressive disorderMedDRA version: 19.0Level: SOCClassification code 10037175Term: Psychiatric disordersSystem Organ Class: 10037175 - Psychiatric disordersMedDRA version: 19.0Level: HLGTClassification code 10012375Term: Depressed mood disorders and disturbancesSystem Organ Class: 10037175 - Psychiatric disordersMedDRA version: 19.0Level: HLTClassification code 10012401Term: Depressive disordersSystem Organ Class: 10037175 - Psychiatric disorders
EUCTR2011-005878-37-ESAziende Chimiche Riunite Angelini Francesco - ACRAF S.p.A.360